vancomycin has been researched along with citric acid, anhydrous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Domen, RE; Williams, L | 1 |
| Celik, AF; Read, NW; Tomlin, J | 1 |
| Adrian, L; Görisch, H; Szewzyk, U | 1 |
| Barralet, JE; Gbureck, U; Hofmann, MP; Mohammed, AR; Perrie, Y | 1 |
| LaPlante, KL; Luther, MK; Mermel, LA | 1 |
| Kaur, A; Kumar, R; Kumar, V; Preet, S | 1 |
| Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC | 1 |
| Hurren, C; Lu, Z; Wang, D; Zhang, J | 1 |
1 trial(s) available for vancomycin and citric acid, anhydrous
| Article | Year |
|---|---|
The effect of oral vancomycin on chronic idiopathic constipation.
Topics: Administration, Oral; Adult; Breath Tests; Citrates; Citric Acid; Constipation; Defecation; Dietary Fiber; Drug Combinations; Female; Gastrointestinal Transit; Humans; Middle Aged; Plant Extracts; Sodium Bicarbonate; Vancomycin | 1995 |
8 other study(ies) available for vancomycin and citric acid, anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vancomycin-induced red cell aggregation.
Topics: Citrates; Citric Acid; Coombs Test; Dose-Response Relationship, Drug; Erythrocyte Aggregation; False Positive Reactions; Ficain; Humans; Sodium Chloride; Vancomycin | 1989 |
Bacterial growth based on reductive dechlorination of trichlorobenzenes.
Topics: Anaerobiosis; Bacteria; Butyrates; Cell Division; Chlorobenzenes; Citric Acid; Culture Media; Fermentation; Oxidation-Reduction; Phosphorylation; Vancomycin; Vitamin B 12 | 2000 |
High-strength resorbable brushite bone cement with controlled drug-releasing capabilities.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Calcium Phosphates; Ciprofloxacin; Citric Acid; Drug Delivery Systems; Microscopy, Electron, Scanning; Models, Chemical; Particle Size; Powders; Pressure; Stress, Mechanical; Vancomycin | 2009 |
Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous cat
Topics: Anti-Infective Agents; Anticoagulants; Central Venous Catheters; Citric Acid; Colony Count, Microbial; Emulsions; Heparin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Temperature; Thiadiazines; Time Factors; Vancomycin | 2014 |
Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Citric Acid; Escherichia coli; Macrophages; Metal Nanoparticles; Mice; Microbial Sensitivity Tests; Molecular Structure; Particle Size; Silver; Staphylococcus aureus; Surface Properties; Vancomycin | 2019 |
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin | 2023 |
pH-sensitive alginate hydrogel for synergistic anti-infection.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Citric Acid; Hydrogels; Hydrogen-Ion Concentration; Vancomycin | 2022 |